The average price target of $27.95 from 11 analysts implies an upside potential for Relay Therapeutics. The decrease in the average price target from the previous average of $34.00 indicates a more conservative outlook, but the overall sentiment remains positive with 3 bullish, 6 somewhat bullish, and 2 indifferent ratings. This suggests that the stock price is likely to go up in the short term.